CDH5 and neoplasm: In previous studies, we have shown that low doses of NGR-TNF, a peptide-TNF fusion protein that targets the tumor vasculature, are sufficient to cause the disassembly VE-cadherin dependent-adherence junctions and gap formation in the tumor endothelium, thereby increasing vascular permeability [38].